| Type |
Details |
Score |
| Publication |
| First Author: |
Chellaiah MA |
| Year: |
2003 |
| Journal: |
Mol Biol Cell |
| Title: |
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. |
| Volume: |
14 |
| Issue: |
1 |
| Pages: |
173-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Päll T |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface. |
| Volume: |
6 |
| Issue: |
12 |
| Pages: |
e29305 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yan Y |
| Year: |
2016 |
| Journal: |
Cancer Res |
| Title: |
KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. |
| Volume: |
76 |
| Issue: |
8 |
| Pages: |
2419-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mott PJ |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis. |
| Volume: |
8 |
| Issue: |
6 |
| Pages: |
e65805 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Iqbal AJ |
| Year: |
2022 |
| Journal: |
FASEB J |
| Title: |
Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. |
| Volume: |
36 |
| Issue: |
1 |
| Pages: |
e22065 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sato MI |
| Year: |
1999 |
| Journal: |
Clin Exp Rheumatol |
| Title: |
CD44 expression on chondrocytes in knees of DBA/1 mice with type II collagen-induced arthritis. |
| Volume: |
17 |
| Issue: |
2 |
| Pages: |
185-90 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chou KJ |
| Year: |
2017 |
| Journal: |
Exp Cell Res |
| Title: |
CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury. |
| Volume: |
350 |
| Issue: |
1 |
| Pages: |
91-102 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ladeda V |
| Year: |
1998 |
| Journal: |
Exp Cell Res |
| Title: |
Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells. |
| Volume: |
242 |
| Issue: |
2 |
| Pages: |
515-27 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Daley SR |
| Year: |
2013 |
| Journal: |
Elife |
| Title: |
Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodies. |
| Volume: |
2 |
|
| Pages: |
e01020 |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; wild type |
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
To K |
| Year: |
2010 |
| Journal: |
Cancer Res |
| Title: |
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. |
| Volume: |
70 |
| Issue: |
7 |
| Pages: |
2840-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Noble PW |
| Year: |
1993 |
| Journal: |
J Clin Invest |
| Title: |
Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. |
| Volume: |
91 |
| Issue: |
6 |
| Pages: |
2368-77 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Barrat F |
| Year: |
1995 |
| Journal: |
Res Immunol |
| Title: |
Quantitative and qualitative changes in CD44 and MEL-14 expression by T cells in C57BL/6 mice during aging. |
| Volume: |
146 |
| Issue: |
1 |
| Pages: |
23-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bradford BM |
| Year: |
2019 |
| Journal: |
Front Cell Neurosci |
| Title: |
Discrimination of Prion Strain Targeting in the Central Nervous System via Reactive Astrocyte Heterogeneity in CD44 Expression. |
| Volume: |
13 |
|
| Pages: |
411 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu LK |
| Year: |
2014 |
| Journal: |
J Med Chem |
| Title: |
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors. |
| Volume: |
57 |
| Issue: |
6 |
| Pages: |
2714-25 |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsukita S |
| Year: |
1997 |
| Journal: |
Trends Biochem Sci |
| Title: |
ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. |
| Volume: |
22 |
| Issue: |
2 |
| Pages: |
53-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Weiss L |
| Year: |
2000 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. |
| Volume: |
97 |
| Issue: |
1 |
| Pages: |
285-90 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lokeshwar VB |
| Year: |
1996 |
| Journal: |
J Biol Chem |
| Title: |
The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. |
| Volume: |
271 |
| Issue: |
39 |
| Pages: |
23853-64 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nakamura H |
| Year: |
1997 |
| Journal: |
J Histochem Cytochem |
| Title: |
Immunolocalization of CD44 and the ezrin-radixin-moesin (ERM) family in the stratum intermedium and papillary layer of the mouse enamel organ. |
| Volume: |
45 |
| Issue: |
11 |
| Pages: |
1481-92 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
318
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1859561 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2022-06-23 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689622 |
| Pattern: |
Regionally restricted |
| Stage: |
TS22 |
| Assay Id: |
MGI:7287753 |
| Age: |
embryonic day 14.5 |
|
| Note: |
Co-localization with Cd44 expression at central domain of array. |
| Specimen Label: |
4E |
| Detected: |
true |
| Specimen Num: |
25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Walzer T |
| Year: |
2002 |
| Journal: |
J Immunol |
| Title: |
Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels. |
| Volume: |
168 |
| Issue: |
6 |
| Pages: |
2704-11 |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1, Frank Hilberg |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 2, Katalin Mikecz |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1, Ursula Gunthert |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1.1, Ursula Gunthert |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 2, Ursula Gunthert |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 2.1, Ursula Gunthert |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1.1, Veronique Orian-Rousseau |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1.1, Michael Karin |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1.2, Michael Karin |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 2, Harwell |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 1, Harwell |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 2, GemPharmatech |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Humanized sequence, Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 3, GemPharmatech |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Humanized sequence, Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 1, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 2, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 3, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 4, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 5, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mitchell BS |
| Year: |
1996 |
| Journal: |
Clin Exp Metastasis |
| Title: |
CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation. |
| Volume: |
14 |
| Issue: |
2 |
| Pages: |
107-14 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
Baseline |
| Source: |
ArrayExpress |
|
•
•
•
•
•
|
| Allele |
| Name: |
deletion, Chr 2, Denis Duboule 43 |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| CL Term |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1, Tak W Mak |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, targeted mutation, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, targeted mutation, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1a, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, congenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 1, Steven T Pals |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; targeted mutation 2, Steven T Pals |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
CD44 antigen; endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129/Sv * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129/Sv * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
DBA/1LacJ-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: BALB/c * DBA/1 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
B6.129-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
B6.129-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
B6.129(Cg)-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
SJL.129(Cg)-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Del(2Cd44-Hoxd11)43Ddu/+ |
| Background: |
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kamazani FM |
| Year: |
2013 |
| Journal: |
Med Oncol |
| Title: |
CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance. |
| Volume: |
30 |
| Issue: |
1 |
| Pages: |
359 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, targeted mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6J |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 |
| Background: |
B6.129P2-Cd44 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|